Home
Resources
Publications
Minoxidil in the Treatment of Androgenetic Alopecia

Minoxidil in the Treatment of Androgenetic Alopecia

Andy Goren, Ty Naccarato

Dermatol Ther. 2018 Sep;31(5):e12686.

PMID: 30155952

Abstract:

The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male pattern hair loss. In the US, minoxidil is approved over-the-counter (OTC) at a maximum concentration of 5%. In this review, we summarize the findings of the pivotal studies used in support of the drug's approval as well as recent discoveries and novel developments in the use of minoxidil for the treatment of AGA.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP38304915-A	Minoxidil		38304-91-5	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: